8-K/A XBRL

FORM 8-K/A

Company: Carisma Therapeutics Inc.
Filed: April 4, 2023
Period of Report: March 7, 2023
Accession Number: 0001104659-23-041238

View Document ↗ View on SEC.gov ↗